Bank of New York Mellon’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-798,073
| Closed | -$8.94M | – | 4449 |
|
|
2017
Q3 | $8.94M | Sell |
798,073
-5,311
| -0.7% | -$59.5K | ﹤0.01% | 2042 |
|
|
2017
Q2 | $8.84M | Sell |
803,384
-23,655
| -3% | -$260K | ﹤0.01% | 2040 |
|
|
2017
Q1 | $8.11M | Buy |
827,039
+24,583
| +3% | +$241K | ﹤0.01% | 2075 |
|
|
2016
Q4 | $8.67M | Buy |
802,456
+60,991
| +8% | +$659K | ﹤0.01% | 2026 |
|
|
2016
Q3 | $7.6M | Buy |
741,465
+143,925
| +24% | +$1.48M | ﹤0.01% | 2005 |
|
|
2016
Q2 | $7.8M | Buy |
597,540
+313,888
| +111% | +$4.1M | ﹤0.01% | 1976 |
|
|
2016
Q1 | $3.12M | Sell |
283,652
-10,207
| -3% | -$112K | ﹤0.01% | 2414 |
|
|
2015
Q4 | $2.7M | Sell |
293,859
-15,215
| -5% | -$140K | ﹤0.01% | 2532 |
|
|
2015
Q3 | $2.15M | Sell |
309,074
-65,381
| -17% | -$454K | ﹤0.01% | 2686 |
|
|
2015
Q2 | $3.68M | Buy |
374,455
+36,970
| +11% | +$363K | ﹤0.01% | 2551 |
|
|
2015
Q1 | $2.99M | Buy |
337,485
+12,668
| +4% | +$112K | ﹤0.01% | 2606 |
|
|
2014
Q4 | $2.85M | Sell |
324,817
-683
| -0.2% | -$5.98K | ﹤0.01% | 2627 |
|
|
2014
Q3 | $2.24M | Sell |
325,500
-16,446
| -5% | -$113K | ﹤0.01% | 2790 |
|
|
2014
Q2 | $1.8M | Sell |
341,946
-6,292
| -2% | -$33.1K | ﹤0.01% | 2965 |
|
|
2014
Q1 | $1.59M | Sell |
348,238
-10,849
| -3% | -$49.4K | ﹤0.01% | 3034 |
|
|
2013
Q4 | $1.81M | Buy |
359,087
+1,136
| +0.3% | +$5.73K | ﹤0.01% | 2946 |
|
|
2013
Q3 | $1.82M | Sell |
357,951
-404
| -0.1% | -$2.05K | ﹤0.01% | 2900 |
|
|
2013
Q2 | $1.78M | Buy |
+358,355
| New | +$1.78M | ﹤0.01% | 2862 |
|